ABSTRACT

Abnormal adnexal masses are a common gynecologic problem that affects women of all ages. Although many of these masses are benign, the primary aim of diagnostic evaluation is to exclude malignancy. In this trial, we aimed to analyze adnexal masses that are referred and operated in our gynecologic oncology clinic.

A total of 1,152 patients operated in our clinic due to suspicious malignancy between 2004 and 2017 were included in this trial. Patient data from the database of the gynecologic oncology clinic were analyzed retrospectively.

Among all included patients, benign pathological results were determined in 529 (45.92%) patients, whereas malignant and borderline tumors were determined in 505 (43.83%) patients and 118 (10.24%) patients, respectively. The median cancer antigen 125 level in the malignancy group was 150 (7-15,554) IU/mL, whereas that in the benign and borderline groups, it was 19 and 29 IU/ mL, respectively.

Many benign masses imitate ovarian cancer. Although some of them can be separated, preoperative careful examination and histological examination are the established diagnostic procedures.